| Biological properties of extracellular vesicles and their physiological functions M Yáñez-Mó, PRM Siljander, Z Andreu, A Bedina Zavec, FE Borràs, ... Journal of extracellular vesicles 4 (1), 27066, 2015 | 5015 | 2015 |
| Applying extracellular vesicles based therapeutics in clinical trials–an ISEV position paper T Lener, M Gimona, L Aigner, V Börger, E Buzas, G Camussi, N Chaput, ... Journal of extracellular vesicles 4 (1), 30087, 2015 | 1192 | 2015 |
| Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow K Bieback, A Hecker, A Kocaömer, H Lannert, K Schallmoser, D Strunk, ... Stem cells 27 (9), 2331-2341, 2009 | 621 | 2009 |
| Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cells K Schallmoser, C Bartmann, E Rohde, A Reinisch, K Kashofer, ... Transfusion 47 (8), 1436-1446, 2007 | 612 | 2007 |
| Human platelet lysate: replacing fetal bovine serum as a gold standard for human cell propagation? T Burnouf, D Strunk, MBC Koh, K Schallmoser Biomaterials 76, 371-387, 2016 | 512 | 2016 |
| Identification of the human skeletal stem cell CKF Chan, GS Gulati, R Sinha, JV Tompkins, M Lopez, AC Carter, ... Cell 175 (1), 43-56. e21, 2018 | 486 | 2018 |
| Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance R Jacamo, Y Chen, Z Wang, W Ma, M Zhang, EL Spaeth, Y Wang, ... Blood, The Journal of the American Society of Hematology 123 (17), 2691-2702, 2014 | 314 | 2014 |
| Manufacturing of human extracellular vesicle-based therapeutics for clinical use M Gimona, K Pachler, S Laner-Plamberger, K Schallmoser, E Rohde International journal of molecular sciences 18 (6), 1190, 2017 | 269 | 2017 |
| Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation A Reinisch, N Etchart, D Thomas, NA Hofmann, M Fruehwirth, S Sinha, ... Blood, the Journal of the American Society of Hematology 125 (2), 249-260, 2015 | 246 | 2015 |
| Humanized large-scale expanded endothelial colony–forming cells function in vitro and in vivo A Reinisch, NA Hofmann, AC Obenauf, K Kashofer, E Rohde, ... Blood, The Journal of the American Society of Hematology 113 (26), 6716-6725, 2009 | 242 | 2009 |
| DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma NC Sheffield, G Pierron, J Klughammer, P Datlinger, A Schönegger, ... Nature medicine 23 (3), 386-395, 2017 | 224 | 2017 |
| A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells A Reinisch, D Thomas, MR Corces, X Zhang, D Gratzinger, WJ Hong, ... Nature medicine 22 (7), 812-821, 2016 | 222 | 2016 |
| Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum K Schallmoser, E Rohde, A Reinisch, C Bartmann, D Thaler, C Drexler, ... Tissue Engineering Part C: Methods 14 (3), 185-196, 2008 | 217 | 2008 |
| Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application A Reinisch, C Bartmann, E Rohde, K Schallmoser, V Bjelic-Radisic, ... Future Medicine Ltd 2 (4), 371-382, 2007 | 214 | 2007 |
| A Good Manufacturing Practice–grade standard protocol for exclusively human mesenchymal stromal cell–derived extracellular vesicles K Pachler, T Lener, D Streif, ZA Dunai, A Desgeorges, M Feichtner, ... Cytotherapy 19 (4), 458-472, 2017 | 199 | 2017 |
| Immune cells mimic the morphology of endothelial progenitor colonies in vitro E Rohde, C Bartmann, K Schallmoser, A Reinisch, G Lanzer, W Linkesch, ... Stem cells 25 (7), 1746-1752, 2007 | 199 | 2007 |
| Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures K Schallmoser, D Strunk JoVE (Journal of Visualized Experiments), e1523, 2009 | 178 | 2009 |
| Two steps to functional mesenchymal stromal cells for clinical application C Bartmann, E Rohde, K Schallmoser, P Pürstner, G Lanzer, W Linkesch, ... Transfusion 47 (8), 1426-1435, 2007 | 156 | 2007 |
| Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions K Schallmoser, C Bartmann, E Rohde, S Bork, C Guelly, AC Obenauf, ... Haematologica 95 (6), 867, 2010 | 154 | 2010 |
| A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance N Ketterl, G Brachtl, C Schuh, K Bieback, K Schallmoser, A Reinisch, ... Stem cell research & therapy 6, 1-11, 2015 | 112 | 2015 |
